UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000063073
Receipt number R000067950
Scientific Title A study on the Effects of Lactosucrose Intake on BowelMovements and PhysicalCondition
Date of disclosure of the study information 2026/10/01
Last modified on 2026/09/28 14:30:06

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A study on the Effects of Lactosucrose Intake on BowelMovements and PhysicalCondition

Acronym

A study on the Effects of Lactosucrose Intake on BowelMovements and PhysicalCondition

Scientific Title

A study on the Effects of Lactosucrose Intake on BowelMovements and PhysicalCondition

Scientific Title:Acronym

A study on the Effects of Lactosucrose Intake on BowelMovements and PhysicalCondition

Region

Japan


Condition

Condition

Adult male and female

Classification by specialty

Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Investigating changes in bowel movements and gut microbiota and physical condition following 8weeks of lactosucrose intake

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Pragmatic

Developmental phase



Assessment

Primary outcomes

1.Frequency of bowel movements and stool consistency
2.Gut microbiota analysis
3.Body weight and blood tests
4.Skin moisture measurement

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Non-randomized

Randomization unit


Blinding

Double blind -all involved are blinded

Control

Placebo

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Food

Interventions/Control_1

The test food (lactosucrose syrup) will be consumed at 8grams per day for 8 weeks

Interventions/Control_2

The placebo food (mizuame) will be consumed at 8grams per day for 8 weeks

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

60 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1.Persons who are 60years old or older
2.Subjects diagnosed with chronic constipation and currently using laxatives
3.Individuals who are able to provide written informed consent to participate in the study,
either personally or through a legal representative, after being informed of the study's purpose and details

Key exclusion criteria

1.Those who are parenteral nutrition management
2.Subjects who showed abnormal abdominal symptoms following intake of the test food
3.Subjects judged to be inappropriate for participation in the study by the principal investigator or a physician involved in the research

Target sample size

50


Research contact person

Name of lead principal investigator

1st name Akemi
Middle name
Last name Matsumura

Organization

Kitayama Takeda Hospital, Koseikai Medical Foundation

Division name

Nutrition Department

Zip code

603-8053

Address

99 Kamigamo Iwagakakiuti-cho Kita-ku,Kyoto-shi,Kyoto,Japan

TEL

075-721-1612

Email

eiyo-k@takedahp.or.jp


Public contact

Name of contact person

1st name Akemi
Middle name
Last name Matsumura

Organization

Doshisha Women's College of Liberal Arts

Division name

Graduate School of Human Life Science, Department of Food and Nutrition

Zip code

602-0893

Address

602 Genbu-cho, Teramachi-nishiiru, Imadegawa-dori, Kamigyo-ku, Kyoto-shi, Kyoto, Japan

TEL

075-251-4211

Homepage URL


Email

is25003@dwc.doshisha.ac.jp


Sponsor or person

Institute

Others

Institute

Department

Personal name



Funding Source

Organization

Others

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Doshisha Women's College of Liberal Arts

Address

602 Genbu-cho, Teramachi-nishiiru, Imadegawa-dori, Kamigyo-ku, Kyoto-shi, Kyoto, Japan

Tel

075-251-4211

Email

is25003@dwc.doshisha.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2026 Year 10 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2026 Year 08 Month 06 Day

Date of IRB

2026 Year 08 Month 06 Day

Anticipated trial start date

2026 Year 10 Month 01 Day

Last follow-up date

2030 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2026 Year 09 Month 28 Day

Last modified on

2026 Year 09 Month 28 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000067950